Panatrophy of Gower: A Rare Localized Cutaneous Atrophy
Panatrophy of Gower (also known as Gower's panatrophy or Gower's local panatrophy) is a rare dermatological condition characterized by sharply demarcated, localized areas of cutaneous atrophy involving the dermis, subcutaneous tissue, and occasionally underlying bone, occurring without preceding inflammation or sclerosis 1.
Clinical Characteristics
The condition presents with the following distinctive features:
- Sharply defined atrophic lesions that are localized rather than generalized
- Involvement of multiple tissue layers: dermis, subcutaneous fat, and rarely bone 1, 2
- Absence of inflammatory or sclerosing processes, distinguishing it from scleroderma and morphea 2
- Hypopigmentation is commonly present, which frequently leads to misdiagnosis as steroid-induced atrophy 1
- Can occur on various body sites including limbs and face (facial hemiatrophy has been reported) 2
Histopathological Findings
Biopsy reveals:
- Loss of dermal thickness
- Marked reduction or loss of subcutaneous tissue
- Absence of inflammation or fibrosis 2
- Diminished fat lobules without significant inflammatory infiltrate
Clinical Significance and Diagnostic Pitfalls
The condition is likely underdiagnosed and more common than previously assumed because it is frequently misdiagnosed as post-steroid atrophy 1. The hypopigmented appearance mimics corticosteroid-induced cutaneous atrophy, leading clinicians to incorrectly attribute the lesions to prior steroid use 1, 3.
Key Distinguishing Features from Steroid-Induced Atrophy:
- No history of corticosteroid injection or application at the affected site
- Sharply demarcated borders (steroid atrophy typically has less defined margins)
- Deeper tissue involvement including subcutaneous fat and potentially bone
- Non-inflammatory pathogenesis on histology
Etiopathogenesis
The underlying cause remains unknown and represents an enigma in dermatology 1. The atrophic process appears to be:
- Non-sclerosing in nature
- Different from the inflammation and fibrosis seen in scleroderma 2
- Not related to vascular compromise or autoimmune mechanisms (unlike lipodystrophy syndromes)
Clinical Recognition
Clinicians should suspect Gower's panatrophy when encountering:
- Localized, well-demarcated atrophic depressions with visible loss of subcutaneous volume
- Hypopigmentation without history of topical or intralesional corticosteroid use
- Absence of preceding trauma, inflammation, or sclerotic changes
- Histology showing tissue loss without inflammation
The condition requires heightened clinical awareness, as it may present more frequently than the sparse literature suggests 1. When evaluating any localized cutaneous atrophy, obtaining a detailed history regarding corticosteroid exposure and performing biopsy when the diagnosis is uncertain can prevent misattribution to iatrogenic causes.